tiprankstipranks
Trending News
More News >
Beta Bionics, Inc. (BBNX)
:BBNX
US Market
Advertisement

Beta Bionics, Inc. (BBNX) Stock Statistics & Valuation Metrics

Compare
21 Followers

Total Valuation

Beta Bionics, Inc. has a market cap or net worth of $660.75M. The enterprise value is $389.82M.
Market Cap$660.75M
Enterprise Value$389.82M

Share Statistics

Beta Bionics, Inc. has 43,470,123 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding43,470,123
Owned by Insiders9.96%
Owned by Institutions0.16%

Financial Efficiency

Beta Bionics, Inc.’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -34.40%.
Return on Equity (ROE)-0.72
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-34.40%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee185.01K
Profits Per Employee-155.56K
Employee Count352
Asset Turnover0.44
Inventory Turnover2.19

Valuation Ratios

The current PE Ratio of Beta Bionics, Inc. is ―. Beta Bionics, Inc.’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.98
Price to FCF0.00
Price to Operating Cash Flow-12.66
PEG Ratio

Income Statement

In the last 12 months, Beta Bionics, Inc. had revenue of 65.12M and earned -54.76M in profits. Earnings per share was -8.60.
Revenue65.12M
Gross Profit35.89M
Operating Income-45.25M
Pretax Income-54.76M
Net Income-54.76M
EBITDA-44.10M
Earnings Per Share (EPS)-8.60

Cash Flow

In the last 12 months, operating cash flow was -57.46M and capital expenditures -4.59M, giving a free cash flow of -62.05M billion.
Operating Cash Flow-57.46M
Free Cash Flow-62.05M
Free Cash Flow per Share-1.43

Dividends & Yields

Beta Bionics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.38
52-Week Price Change-36.62%
50-Day Moving Average15.80
200-Day Moving Average
Relative Strength Index (RSI)47.46
Average Volume (3m)578.53K

Important Dates

Beta Bionics, Inc. upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateJul 29, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date

Financial Position

Beta Bionics, Inc. as a current ratio of 6.29, with Debt / Equity ratio of 2.22%
Current Ratio6.29
Quick Ratio5.66
Debt to Market Cap0.01
Net Debt to EBITDA0.53
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Beta Bionics, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Beta Bionics, Inc. EV to EBITDA ratio is -2.89, with an EV/FCF ratio of -2.46.
EV to Sales1.95
EV to EBITDA-2.89
EV to Free Cash Flow-2.46
EV to Operating Cash Flow-2.64

Balance Sheet

Beta Bionics, Inc. has $249.72M in cash and marketable securities with $6.69M in debt, giving a net cash position of -$243.03M billion.
Cash & Marketable Securities$249.72M
Total Debt$6.69M
Net Cash-$243.03M
Net Cash Per Share-$5.59
Tangible Book Value Per Share$11.94

Margins

Gross margin is 53.93%, with operating margin of -69.48%, and net profit margin of -84.08%.
Gross Margin53.93%
Operating Margin-69.48%
Pretax Margin-84.08%
Net Profit Margin-84.08%
EBITDA Margin-67.72%
EBIT Margin-69.48%

Analyst Forecast

The average price target for Beta Bionics, Inc. is $22.21, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$22.21
Price Target Upside40.48% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast97.91%
EPS Growth Forecast-34.11%

Scores

Smart Score4
AI Score63
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis